Fontenay Sous Bois, France

Pascale Beurdeley

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pascale Beurdeley: Innovator in Alzheimer's Disease Diagnosis

Introduction

Pascale Beurdeley is a notable inventor based in Fontenay Sous Bois, France. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of Alzheimer's disease. His innovative work has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Pascale Beurdeley holds a patent for a process and method for diagnosing Alzheimer's disease. This invention focuses on methods and compositions that can be used for diagnosing Alzheimer's disease in mammals, especially humans. It describes serum markers for Alzheimer's disease and their application in diagnostic methods. The invention also includes tools and kits that can be utilized to implement these methods, such as reagents, probes, primers, antibodies, chips, and cells. This invention is particularly valuable for detecting the presence or progression of Alzheimer's disease in its early phases and for predicting the efficacy of treatments.

Career Highlights

Throughout his career, Pascale Beurdeley has worked with various companies, including Exonhit Therapeutics and Exonhit S.A. His experience in these organizations has contributed to his expertise in the field of medical diagnostics and innovation.

Collaborations

Pascale has collaborated with notable individuals in his field, including Anne-Charlotte Jarrige-Le Prado and Diego Pallares. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Pascale Beurdeley is a distinguished inventor whose work in diagnosing Alzheimer's disease showcases his commitment to advancing medical science. His innovative methods and tools have the potential to significantly enhance early detection and treatment efficacy for this challenging condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…